3-D Matrix, Ltd. (TYO:7777)
293.00
-5.00 (-1.68%)
Oct 7, 2025, 3:30 PM JST
3-D Matrix Revenue
3-D Matrix had revenue of 2.19B JPY in the quarter ending July 31, 2025, with 47.74% growth. This brings the company's revenue in the last twelve months to 7.64B, up 45.69% year-over-year. In the fiscal year ending April 30, 2025, 3-D Matrix had annual revenue of 6.93B with 51.13% growth.
Revenue (ttm)
7.64B
Revenue Growth
+45.69%
P/S Ratio
4.38
Revenue / Employee
67.04M
Employees
114
Market Cap
33.48B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Apr 30, 2025 | 6.93B | 2.35B | 51.13% |
Apr 30, 2024 | 4.59B | 2.27B | 98.27% |
Apr 30, 2023 | 2.31B | 808.00M | 53.65% |
Apr 30, 2022 | 1.51B | 482.00M | 47.07% |
Apr 30, 2021 | 1.02B | 352.00M | 52.38% |
Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,196.21B |
HOYA Corporation | 876.09B |
Daiichi Sankyo Company | 1,924.68B |
Takeda Pharmaceutical Company | 4,480.25B |
Otsuka Holdings | 2,401.70B |
Terumo | 1,037.94B |
Astellas Pharma | 1,944.99B |
Shionogi & | 440.50B |